Bank of Montreal
XRTX

Bank of Montreal’s XORTX Therapeutics XRTX Stock Holding History

Bank of Montreal’s Portfolio XRTX Stock Details XRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,999
Closed -$59.8K – 4295
2024
Q1 		$59.8K Buy
+2,999
New +$47K ﹤0.01% 3410

Other funds holding XRTX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

Bank of Montreal's XRTX Position: Q2 2024 in Review

Bank of Montreal sold out of XORTX Therapeutics (XRTX) in Q2 2024, closing a stake of 2,999 shares — an estimated $59.8K sold.

Bank of Montreal first reported a position in XRTX in Q1 2024 and held it in 1 quarter. The position peaked at $59.8K in Q1 2024. 5 funds tracked by Wall St. Rank hold XRTX as of Q2 2024.

  • Bank of Montreal reported no remaining XORTX Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 2,999 XORTX Therapeutics shares in Q2 2024, an estimated $59.8K.
  • Bank of Montreal first reported a position in XORTX Therapeutics in Q1 2024 and held it in 1 quarter.
  • Bank of Montreal's XORTX Therapeutics position peaked at $59.8K in Q1 2024.
  • 5 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.